NANOVIRICIDES, INC. Payments of Stock Issuance Costs
NANOVIRICIDES, INC. (NNVC) had Payments of Stock Issuance Costs of $1.06 million as of 2020-07-10, per its 10-Q filed 2021-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2021-02-16
- 2020-07-10: Payments of Stock Issuance Costs $1.06M.
- 2020-01-25: Payments of Stock Issuance Costs $1.17M.
| Period end | Payments of Stock Issuance Costs |
|---|---|
| 2020-07-10 | $1.06M 10-Q · filed 2021-02-16 |
| 2020-01-25 | $1.17M 10-Q · filed 2020-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |